Gene expression and pharmacodynamic-induced changes in 1760 SLE Patients from two phase III trials of B cell activating factor blockade with tabalumab - refine.bio

GSE88887

Homo sapiens

1190 Downloadable Samples

Technology Badge Icon

Affymetrix Human Transcriptome Array 2.0 (hta20)

Submitter Supplied Information

Description

This SuperSeries is composed of the SubSeries listed below.

PubMed ID

Publication Title

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

Total Samples

1202

Submitter’s Institution

Eli Lilly and Company

Authors

Hoffman RW, Merrill JT, Alarcón-Riquelme MM, Petri M, Dow ER, Nantz E, Nisenbaum LK, Schroeder KM, Komocsar WJ, Perumal NB, Linnik MD, Airey DC, Liu Y, Rocha GV, Higgs RE

Source Repository

Gene Expression Omnibus (GEO)

No rows found

Loading...